drugset / Trial / NCT05456334

New Treatments for Actinic Keratoses of the Scalp

NCT05456334

RandomizedParallel-groupSingle-blindTreatment

Summary

This blinded controlled 2-year study on 120 patients with 2 or more actinic keratoses, compare the efficacy and tolerability of pulsed dye-laser- mediated photodynamic therapy compared to conventional photodynamic therapy and fractional-laser assisted daylight photodynamic therapy compared to daylight photodynamic therapy.

Timeline

Start
2016-03-24
Primary completion
2023-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Background methyl aminolevulinate Small molecule Topical

Indications